SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
413>> In fact, the whole concept of "inverse agonism" being relevanscaram(o)uche-4/9/2007
412No apologies needed; I was clearly confused, and your explanation is a big help.tuck-4/7/2007
411<<So they are apparently looking for an inverse agonist that will have thetommysdad-4/7/2007
410[In vitro pharmacology of clinically used CNS active drugs as inverse H1 receptotuck-4/5/2007
409Nice job. Of course the last nice job like this one, was RPRX. And it has goneRobohogs-4/4/2007
408ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering Wednesday Apriscaram(o)uche-4/4/2007
407Maybe yesterday morning was our attractive re-entry point?sjemmeri-4/3/2007
406>>ACADIA Pharmaceuticals Announces Proposed Public Stock Offering Monday Atuck-4/2/2007
405>> Another entrant??? << No overlap, from an indication stand. No scaram(o)uche-3/29/2007
404Another entrant??? Or are 5-HT1A and 5-HT2A completely non-overlapping? .EPIXIan@SI-3/29/2007
403ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 Iscaram(o)uche-3/29/2007
402Forbes: Double Dose Of Good News For Acadia Evelyn M. Rusli, 03.19.07, 6:25 PM mopgcw-3/25/2007
401cramer bearish on ACAD (Last Q of Lightning Round) recommended NSTK instead.Ian@SI-3/23/2007
400Fewer side effects seen in schizophrenia study By Penni Crabtree UNION-TRIBUNE Ssim1-3/20/2007
399You and Tuck have convinced me. I'm now out. Besides for the past 2 weeks Ian@SI-3/20/2007
398I will be interested to see the full data set for efficacy and improvement in SEdr.praveen-3/20/2007
397Praveen, I agree. Further, the improvement in weight gain is not broken out, sotuck-3/20/2007
396Thanks, makes good sense. If ACAD trades another 3M shares in the next 10 minutIan@SI-3/19/2007
395Hi Ian, I am taking my profits today just to lock my gains. It is the 2nd time dr.praveen-3/19/2007
394Dr. P., Congrats on your realized profit. With just under 30M shares outstandiIan@SI-3/19/2007
393fwiw, i am taking profits on 1/2, will hold a small position for further excitemmopgcw-3/19/2007
392Congrats to all of the holders here. I am taking profits on my little position. dr.praveen-3/19/2007
391ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapysim1-3/19/2007
390[Characterization of the Mas-related gene family: structural and functional constuck-1/17/2007
389I had to bail when it was in the $7's. Sorry should have posted here. Too Tom Caruthers-1/16/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News